Investigator Grant Payments

INVESTIGATOR GRANT PAYMENTS WHITE PAPERS AND CASE STUDIES

INVESTIGATOR GRANT PAYMENTS PRODUCTS & SERVICES

Marki Microwave waveguide twists provide accurate offsets and directional changes for waveguide transmission lines and are built with high precision and then gold plated for high corrosion resistance.

Scout delivers patient engagement solutions that keep participants involved in clinical trials while supporting sites, sponsors, and CROs.

With tools that manage payments, travel, and communication, we make it easy for participants to stay connected and confident throughout their trial journey.

By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.

The AI-driven process management platform for modern clinical development. Judi unifies fragmented workflows and accelerates execution from protocol to submission.

CPI EDB presents the VSS3607 GaN solid state power amplifier (SSPAs) operating in the S-band (2.7 – 2.9 GHz). These high efficiency, high power, compact amplifiers are easy to maintain, and are designed for use in air surveillance radar applications.

The leading GIS-centric solution for permitting, licensing and land management—designed to simplify workflows for customers and staff. Improve public services and cross-team collaboration with a digital solution that keeps pace with the changes in your community.

With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.

Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.

INVESTIGATOR GRANT PAYMENTS NEWS

  • Researchers Develop Molecular Qubits That Communicate At Telecom Frequencies
    10/2/2025

    A team of scientists from the University of Chicago, the University of California Berkeley, Argonne National Laboratory, and Lawrence Berkeley National Laboratory has developed molecular qubits that bridge the gap between light and magnetism—and operate at the same frequencies as telecommunications technology.

  • Yokogawa Co-Awarded DARPA Project To Advance Oceanic Energy Harvesting
    1/8/2025

    Yokogawa Corporation of America, a provider of advanced solutions in the areas of measurement, control, and information, is pleased to announce that a collaborative team including Yokogawa has been awarded a research project by the Defense Advanced Research Projects Agency (DARPA) to develop and test a biologically fueled energy source to power research and sensing devices throughout the world’s oceans.

  • Klarna Signs With J.P. Morgan Payments To Expand Merchant Services Offering
    2/11/2025

    Klarna, the AI-powered global payments network and shopping assistant, has signed an agreement with J.P. Morgan Payments that will, for the first time, make Klarna’s Buy Now, Pay Later (BNPL) payment options available to businesses that rely on J.P. Morgan Payments for payment processing.

  • iPiD Partners With Mazepay To Accelerate Secure Supplier Onboarding And Payments
    2/10/2026

    iPiD, a global provider of Know Your Payee (KYP) or real-time payee and account verification solutions, today announced a partnership with Mazepay, a process platform that helps large enterprises streamline procurement, supplier compliance, and invoice payments.

  • ReciBioPharm Secures A Significant Grant To Advance RNA Manufacturing
    1/13/2025

    ReciBioPharm, a division of Recipharm and a leading Contract Development and Manufacturing Organisation (CDMO), has been awarded a three-year grant from the Bill & Melinda Gates Foundation (Gates Foundation).

ABOUT

Investigator Grant Payments
In the clinical trials industry, there is usually the pressure of making profits while maintaining regulatory compliance. In order to maximize on their research and development spending, pharmaceutical companies are reducing clinical trial cycle times.
However, there are an increasing number of clinical trials, with more complex protocols and more stringent regulatory requirements. Despite all these, many sponsors issue late payments to investigative sites, and many of these sites are struggling to maintain financial viability.
If the sponsors want to maintain strong, effective investigative sites, they need to build strong relationships with them. This involves coming up with a more effective approach to investigator grant payments. This will not only improve investigator relationships and satisfaction, it will help sponsors to accelerate cycle times and reduce the costs of clinical trials.
First, there is a need to understand that accounts payable in the clinical trials industry are very complex. Investigator grant payments are driven by the terms of the clinical trial agreement. These agreements are highly complex documents with various variables that can impact on the grant payment.
There is also a need for better management of investigator grant payments through the right personnel. Apart from having a background in finance and accounting, those in charge ought to have some experience in financial management of clinical trials.
Such a person would understand the standard process for a clinical trial, from screening to treatment of patients. He or she should be able to read and understand how the clinical study is progressing against the clinical trial agreement.